VAERS reports by lot

Novartis Vaccines Meningococcal lot G7KX2: VAERS reports

37 VAERS reports list lot G7KX2 as a Novartis Vaccines Meningococcal vaccine, received between 2023-07-25 and 2024-08-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal1422%
General / Systemic (non-local)1117%
Neurological914%
Injection-site / Local reaction914%
Cardiac / Cardiovascular58%
Allergic / Anaphylactic58%
Dermatological (non-injection-site)58%
Gastrointestinal35%
Respiratory23%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Texas6
New York3
Pennsylvania3
Nebraska2
Ohio2
Virginia2
Massachusetts2
Minnesota1
Kentucky1
Iowa1
South Dakota1

Reports by month received

2023-073
2023-088
2023-091
2023-103
2023-112
2024-011
2024-021
2024-0414
2024-051
2024-061
2024-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.